Impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
09 Nov 2023
Historique:
medline: 10 11 2023
pubmed: 10 11 2023
entrez: 10 11 2023
Statut: aheadofprint

Résumé

In the context of primary mitral regurgitation (PMR), the selection of patients for transcatheter edge-to-edge repair (TEER) does not include a systematic assessment of PMR-associated cardiac remodelling. We aimed to investigate the epidemiology and prognostic significance of different phenotypes of extra-mitral valve (MV) cardiac involvement in a large series of patients with PMR referred for TEER. The study included 654 patients from the multicentre Italian GIOTTO registry, stratified into groups according to extra-mitral valve (MV) cardiac involvement. The primary endpoint was all-cause death at 2-year follow-up. Patients with no cardiac involvement (NI; n=58), left heart involvement (LHI; n=343) and right heart involvement (RHI; n=253) were analysed. Acute technical success was achieved in 98% of patients. Kaplan-Meier curve analysis revealed significantly worse survival in patients with LHI and RHI (p=0.041). On multivariate Cox regression analysis, extra-MV cardiac involvement, haemoglobin level and technical success were independent predictors of the primary endpoint occurrence. Grading cardiac involvement may help refine risk stratification, since at least 1 group of extra-MV cardiac involvement represents in itself a negative predictor of midterm outcome.

Sections du résumé

BACKGROUND BACKGROUND
In the context of primary mitral regurgitation (PMR), the selection of patients for transcatheter edge-to-edge repair (TEER) does not include a systematic assessment of PMR-associated cardiac remodelling.
AIMS OBJECTIVE
We aimed to investigate the epidemiology and prognostic significance of different phenotypes of extra-mitral valve (MV) cardiac involvement in a large series of patients with PMR referred for TEER.
METHODS METHODS
The study included 654 patients from the multicentre Italian GIOTTO registry, stratified into groups according to extra-mitral valve (MV) cardiac involvement. The primary endpoint was all-cause death at 2-year follow-up.
RESULTS RESULTS
Patients with no cardiac involvement (NI; n=58), left heart involvement (LHI; n=343) and right heart involvement (RHI; n=253) were analysed. Acute technical success was achieved in 98% of patients. Kaplan-Meier curve analysis revealed significantly worse survival in patients with LHI and RHI (p=0.041). On multivariate Cox regression analysis, extra-MV cardiac involvement, haemoglobin level and technical success were independent predictors of the primary endpoint occurrence.
CONCLUSIONS CONCLUSIONS
Grading cardiac involvement may help refine risk stratification, since at least 1 group of extra-MV cardiac involvement represents in itself a negative predictor of midterm outcome.

Identifiants

pubmed: 37946539
pii: EIJ-D-23-00548
doi: 10.4244/EIJ-D-23-00548
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Antonio Popolo Rubbio (A)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Antonio Sisinni (A)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Alice Moroni (A)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Marianna Adamo (M)

Cardiac Catheterisation Laboratory and Cardiology, ASST Spedali Civili di Brescia, Brescia, Italy and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Carmelo Grasso (C)

Division of Cardiology, Centro Alte Specialità e Trapianti (CAST), AOU Policlinico "G. Rodolico - S. Marco", University of Catania, Catania, Italy.

Matteo Casenghi (M)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Maurizio B Tusa (MB)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Marta Barletta (M)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Paolo Denti (P)

Cardiac Surgery Department, San Raffaele University Hospital, Milan, Italy.

Arturo Giordano (A)

Invasive Cardiology Unit, Pineta Grande Hospital, Castel Volturno, Italy.

Federico De Marco (F)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Antonio L Bartorelli (AL)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Matteo Montorfano (M)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy and Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Cosmo Godino (C)

Cardio-Thoracic-Vascular Department, San Raffaele University Hospital, Milan, Italy.

Eustachio Agricola (E)

Cardio-Thoracic-Vascular Department, San Raffaele University Hospital, Milan, Italy.

Rodolfo Citro (R)

University Hospital San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
Department of Vascular Physiopathology, IRCCS Neuromed, Pozzilli, Italy.

Francesco De Felice (F)

Division of Interventional Cardiology, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy.

Annalisa Mongiardo (A)

Division of Cardiology, University Magna Graecia, Catanzaro, Italy.

Ida Monteforte (I)

AORN Ospedali dei Colli, Monaldi Hospital, Naples, Italy.

Emmanuel Villa (E)

Valve Center, Poliambulanza Foundation Hospital, Brescia, Italy.

Anna Sonia Petronio (AS)

Cardiac Catheterisation Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Cristina Giannini (C)

Cardiac Catheterisation Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Gabriele Crimi (G)

Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Giulia Masiero (G)

Department of Cardiac, Thoracic and Vascular Science, Interventional Cardiology Unit, University of Padua, Padua, Italy.

Giuseppe Tarantini (G)

Department of Cardiac, Thoracic and Vascular Science, Interventional Cardiology Unit, University of Padua, Padua, Italy.

Luca Testa (L)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Corrado Tamburino (C)

Division of Cardiology, Centro Alte Specialità e Trapianti (CAST), AOU Policlinico "G. Rodolico - S. Marco", University of Catania, Catania, Italy.

Francesco Bedogni (F)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Classifications MeSH